Company intelligence / Profile preview

Health 'N' U Therapeutics

Mumbai, Maharashtra, Indiain.linkedin.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Health 'N' U Therapeutics markets a range of differentiated and first-in-country small-molecule combination drugs primarily for neuropathic pain, migraine, and associated neurological disorders, including landmark launches such as India's first amitriptyline + mecobalamin and amitriptyline + propranolol formulations. At least two phase IV clinical studies have been conducted for marketed drugs.[1][3]

Therapeutic areas: PsychiatryEndocrinologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

NuLink Co. Ltd. (Japan)

Beyond the preview

Go deeper on Health 'N' U Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Health 'N' U Therapeutics.

Explore the full profile